World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
32270
World Ranking
1242
National Ranking
648

Medicine

D-Index
86
Citations
32299
World Ranking
13970
National Ranking
7088

Effie W. Petersdorf publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Effie W. Petersdorf sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 343 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Effie W. Petersdorf D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Effie W. Petersdorf sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Effie W. Petersdorf is affiliated with the University of Washington in the United States. Their research primarily focuses on medicine and immunology and microbiology, with a significant number of publications in these fields.

Their work covers several subfields, including immunology, hematology, transplantation, public health, environmental and occupational health, and oncology. Key topics addressed by their research include hematopoietic stem cell transplantation, T-cell and B-cell immunology, immune cell function and interaction, renal transplantation outcomes and treatments, cancer survivorship and care, blood groups and transfusion, and palliative care and end-of-life issues.

Effie W. Petersdorf has contributed to a range of scientific journals and venues. Most frequently, their publications have appeared in:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Journal of Clinical Oncology
  • Haematologica

Recent papers published by Effie W. Petersdorf include:

  • Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation, 2020, Journal of Clinical Oncology
  • HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation, 2020, Blood
  • HLA-DQ heterodimers in hematopoietic cell transplantation, 2022, Blood

They also contributed to research on broader topics such as risk prediction after stem cell transplantation and patient perspectives on palliative care, with papers including:

  • HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide, 2021, Blood
  • What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients, 2023, Blood Advances

Effie W. Petersdorf frequently collaborates with other researchers. Notable frequent coauthors include:

  • Stephen R. Spellman
  • Stephanie J. Lee
  • Ted Gooley
  • Caroline McKallor
  • Yung-Tsi Bolon

Best Publications

  • Nomenclature for factors of the HLA system, 2010.

    S G. E. Marsh;E. D. Albert;W. F. Bodmer;R. E. Bontrop

  • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

    Stephanie J. Lee;John Klein;Michael Haagenson;Lee Ann Baxter-Lowe

  • Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

    Neal Flomenberg;Lee Ann Baxter-Lowe;Dennis Confer;Marcelo Fernandez-Vina

  • Nomenclature for factors of the HLA system, 2004

    Steven G.E. Marsh;E. D. Albert;W. F. Bodmer;R. E. Bontrop

  • Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia

    John A. Hansen;Theodore A. Gooley;Paul J. Martin;Frederick Appelbaum

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

    Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  • Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient

    Effie W. Petersdorf;Theodore A. Gooley;Claudio Anasetti;Paul J. Martin

  • HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1

    Jeffrey M. Venstrom;Gianfranco Pittari;Ted A. Gooley;Joseph H. Chewning

  • Cord-Blood Transplantation in Patients with Minimal Residual Disease

    Filippo Milano;Ted Gooley;Brent Wood;Ann Woolfrey

  • Transplantation of Marrow Cells From Unrelated Donors for Treatment of High-Risk Acute Leukemia: The Effect of Leukemic Burden, Donor HLA- Matching, and Marrow Cell Dose

    Jorge Sierra;Barry Storer;John A. Hansen;Jean W. Bjerke

  • Major-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation

    Effie W. Petersdorf;John A. Hansen;Paul J. Martin;Ann Woolfrey

  • Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

    J.T. Slattery;R.A. Clift;C.D. Buckner;J. Radich

  • Nomenclature for factors of the HLA system, 2002

    Steven G. E. Marsh;Ekkehard D. Albert;Walter F. Bodmer;Ronald E. Bontrop

  • Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study

    Katharina Fleischhauer;Bronwen E. Shaw;Bronwen E. Shaw;Theodore Gooley;Mari Malkki

  • HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

    Michael B. Maris;Dietger Niederwieser;Brenda M. Sandmaier;Barry Storer

  • The Significance of HLA-DRB1 Matching on Clinical Outcome After HLA-A, B, DR Identical Unrelated Donor Marrow Transplantation

    Effie W. Petersdorf;Gary M. Longton;Claudio Anasetti;Paul J. Martin

  • Limits of HLA mismatching in unrelated hematopoietic cell transplantation

    Effie W. Petersdorf;Claudio Anasetti;Paul J. Martin;Ted Gooley

  • Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

    Patrick Beatty;John Hansen;Gary Longton;E. Thomas

  • Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

    H. Joachim Deeg;Barry Storer;John T. Slattery;Claudio Anasetti

  • Nomenclature for factors of the HLA system, 2004.

    Unknown

Frequent Co-Authors

Claudio Anasetti
Claudio Anasetti Fred Hutchinson Cancer Research Center
John A. Hansen
John A. Hansen Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Stephen R. Spellman
Stephen R. Spellman Medical College of Wisconsin
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Eric Mickelson
Eric Mickelson Fred Hutchinson Cancer Research Center
John P. Klein
John P. Klein Medical College of Wisconsin
Machteld Oudshoorn
Machteld Oudshoorn Leiden University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology and healthcare, pursuing online nursing degrees can open diverse career opportunities. Many students start with online ADN programs for non nurses, which provide foundational training for a nursing career without prior healthcare experience.

Advancing further, accelerated options are available, such as accelerated NP programs online. These programs are ideal for individuals seeking to become nurse practitioners efficiently while balancing work or personal commitments.

For nurse practitioners, bridging specialties is a common pathway. The FNP to acute care NP bridge program offers a focused transition from family nursing to acute care, expanding clinical expertise and career focus.

Understanding the financial prospects of these roles is also crucial. The doctor of nursing practice salary overview provides insight into earnings potential across different states, helping students plan their educational investments and career paths strategically.

Best Scientists Citing Effie W. Petersdorf

Trending Scientists

Recently Published Articles